Infection Control Market Report 2025

The infection control market size has grown strongly in recent years. It will grow from $127.09 billion in 2024 to $134.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to healthcare-associated infections (HAIs), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure.

The infection control market size is expected to see strong growth in the next few years. It will grow to $180.72 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to pandemic preparedness, growing healthcare infrastructure, rising antimicrobial resistance, evolving regulatory landscape, public health initiatives. Major trends in the forecast period include technological integration in healthcare, technological innovations in infection control products, technological advancements in disinfection, increased emphasis on hand hygiene, rapid sterilization techniques.

The growth of the infection control market is expected to be propelled by the increasing incidence of hospital-acquired infections. Hospital-acquired infections, also known as healthcare-associated infections, are contracted by patients within healthcare facilities. These infections include conditions such as bloodstream infections and urinary tract infections linked to central-line catheters. Infection control plays a crucial role in preventing the transmission of communicable diseases in healthcare settings through high-level services, hygiene, and sterilization practices. The ease of these infection control measures contributes to the market's growth. As of May 2022, the World Health Organization reported that over 24% of patients worldwide were affected by healthcare-associated infections. Additionally, estimates from the Centers for Disease Control and Prevention (CDC) in the US indicated that hospital-acquired infections accounted for around 1.7 million infections and 99,000 associated deaths annually by 2022, with a projected increase in the future. Thus, the rising incidence of hospital-acquired infections is a driving factor for the infection control market.

The rise in surgical procedures is expected to propel the growth of the infection control market in the coming years. A surgical procedure refers to a medical intervention or operation carried out by a qualified surgeon or medical professional to treat a disease, address a health issue, or repair a bodily structure. As the number of surgical procedures increases, there is a greater demand for effective sterilization and disinfection practices for surgical instruments, equipment, and operating rooms, thereby promoting the adoption of infection control products and services. For example, in August 2023, The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing number of surgical procedures is driving the expansion of the infection control market.

Major companies in the infection control market are focusing on developing intuitive user interface designs, enabling healthcare professionals to easily access tools for monitoring cleanliness and tracking infection rates, thereby enhancing patient safety and operational efficiency. Intuitive design refers to creating products or interfaces that are user-friendly and straightforward, reducing the need for instructions or prior knowledge. For instance, in January 2024, ICP Medical, a U.S.-based infection prevention company, launched a new website aimed at improving user experience while reflecting its mission of "Helping Those Who Help Others." This updated platform consolidates ICP Medical’s infection control products, including Rapid Refresh quick-change privacy curtains and the BootieButler automatic shoe cover system, creating a convenient “one-stop shop” for customers. In line with TEAM Technologies’ branding, the website caters to healthcare, industrial, and government sectors, featuring an easy-to-navigate design. Key features include seamless e-commerce capabilities, comprehensive product displays, FAQs, downloadable resources, and engaging instructional videos to streamline the purchasing process. Additionally, a dedicated page for privacy curtain samples showcases various patterns and styles, emphasizing ICP Medical’s commitment to accessible and effective infection prevention solutions.

Technological advancements in sterilization equipment are a significant trend in the infection control supplies market. Leading companies in this sector are developing innovative solutions, such as sterilizers, to improve the effectiveness and efficiency of sterilization processes. A sterilizer is a device that eradicates all microbial life on instruments through heat, steam, or chemicals, ensuring they are safe for reuse in medical and dental environments. For example, in January 2024, W&H Dentalwerk Burmoos GmbH, an Austria-based dental technology firm, introduced the Lexa Plus sterilizer as a new innovation in infection control. The Lexa Plus sterilizer is designed to enhance the sterilization process with features such as rapid cycle times, intuitive controls, and advanced monitoring capabilities. This cutting-edge equipment not only guarantees effective sterilization of dental instruments but also includes user-friendly technology that simplifies operation for dental professionals. By improving efficiency and safety, the Lexa Plus aims to address the evolving needs of dental practices while promoting higher standards of infection prevention and patient care.

In December 2022, Paras Healthcare, an India-based healthcare company, formed a partnership with Polymed for an undisclosed amount. This collaboration aims to strengthen their infection control initiatives by incorporating advanced medical technologies and innovative solutions into their healthcare facilities. Polymed, also based in India, specializes in the manufacturing and supply of a diverse range of healthcare products.

Major companies operating in the infection control market include Belimed AG, 3M Company, Ecolab Inc., Advanced Sterilization Products Services Inc., Getinge AB, Matachana Group, Miele Group, Sotera Health Inc., Steris plc., Reckitt Benckiser Group plc., Pal International, Metrex Research LLC, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Fortive Corporation, Cantel Medical Corporation, MELAG Medizintechnik GmbH & Co. KG, The HUBSCRUB Company, Daniels Corporation International Pty. Ltd., Infection Control Consulting Services, Becton Dickinson and Company, Infection Control Results, Sterigenics International LLC, Bioquell Inc., Sterilmed Inc., Conmed Corporation, Johnson & Johnson.

North America was the largest region in the infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global infection control market report during the forecast period. The regions covered in the infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Infection control is the practice of preventing or halting the spread of illnesses in healthcare settings and other environments where the risk of infection is high. It aims to provide a high level of protection for patients, medical personnel, and others in healthcare settings, ultimately preventing the transmission of communicable diseases.

The main types of products and services used in infection control include disinfectors, sterilization equipment, consumables and accessories, and various services. Disinfectors encompass the company's endoscope disinfector products and standard accessories as a whole. These products are distributed through methods such as direct tenders, retail sales, and third-party distributors. They find applications in various areas, including the disinfection of surgical instruments, endoscopes, ultrasound probes, and other related applications. Major end-users of infection control products and services include hospitals and clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other relevant sectors.

The infection control market research report is one of a series of new reports that provides infection control market statistics, including infection control industry global market size, regional shares, competitors with a infection control market share, detailed infection control market segments, market trends and opportunities, and any further data you may need to thrive in the infection control industry. This infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection control market includes revenues earned by entities by providing services such as environmental infection control, hand hygiene services, isolation precautions, and safe injection practice services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.